Combined pharmacotherapy and cognitive-behavioural therapy for anxiety disorders

@article{Pull2007CombinedPA,
  title={Combined pharmacotherapy and cognitive-behavioural therapy for anxiety disorders},
  author={Charles B. Pull},
  journal={Current Opinion in Psychiatry},
  year={2007},
  volume={20},
  pages={30–35}
}
  • C. Pull
  • Published 1 January 2007
  • Psychology, Medicine
  • Current Opinion in Psychiatry
Purpose of review Both pharmacotherapy and cognitive-behavioural therapy are effective treatments for anxiety disorders. The present editorial reviews the current status of combination treatments with a focus on randomized controlled trials, meta-analyses and reviews that have been published in the past 3 years. Recent findings Recent studies on treatments combining pharmacotherapy and cognitive-behavioural therapy for anxiety disorders have found little benefit for combination therapies versus… 
Combined Treatments (Medications plus Psychotherapy)
TLDR
Limitations of the current state of the evidence are highlighted, as well as areas in which additional research is needed to better determine the efficacy of combined treatment over either monotherapy.
Pharmacotherapy of panic disorder
TLDR
Treatment results obtained with CBT compare well with pharmacotherapy, with evidence that CBT is at least as effective as pharmac Therapy, but only in the acute-phase treatment.
Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.
TLDR
The effects of therapist-supported Internet CBT on remission of anxiety disorder diagnosis and reduction of anxiety symptoms in adults as compared to waiting list control, unguided CBT, or face-to-face CBT were assessed.
Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.
TLDR
The effects of therapist-supported Internet CBT on remission of anxiety disorder diagnosis and reduction of anxiety symptoms in adults as compared to waiting list control, unguided CBT, or face-to-face CBT were assessed and effects of treatment on quality of life and patient satisfaction with the intervention were assessed.
Galantamine as Adjunctive Treatment for Ameliorating Negative Symptoms of Schizophrenia Patients
TLDR
It is indicated that galantamine could significantly affect the severity of the symptoms of schizophrenia patients and suggest galantine as an appropriate adjunctive treatment for ameliorating negative symptoms, especially attention and alogia.
Escitalopram for Persistent Symptoms of Generalized Anxiety Disorder After CBT: A Pilot Study
TLDR
Cognitive behavioral therapy (CBT) and pharmacotherapy are each efficacious for generalized anxiety disorder (GAD), but whether GAD partial and nonresponders to one treatment modality benefit from the other is unknown.
Comparative Efficacy and Acceptability of Pharmacological, Psychotherapeutic, and Combination Treatments in Adults With Posttraumatic Stress Disorder: A Network Meta-analysis.
TLDR
These results suggest superiority of psychotherapeutic treatments over pharmacological treatments in improving PTSD symptom severity in the long term, and network, but not pairwise, meta-analyses suggest superiority.
Anxiety management: Participants’ experiences of a physiotherapeutic group treatment in Swedish psychiatric outpatient care
TLDR
It is suggested that a physiotherapeutic group treatment can be a useful add-on treatment to the standard treatment models of anxiety disorders, including psychotherapy and pharmacotherapy, since it targets the embodied, nonverbal domain of anxiety.
Diagnosis and management of generalized anxiety disorder and panic disorder in adults.
TLDR
Treatment of GAD and PD often includes medications such as selective serotonin reuptake inhibitors and/or psychotherapy, both of which are highly effective, and cognitive behavior therapy has been studied widely and has an extensive evidence base.
HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: where do we stand?
TLDR
Recent evidence from pre-clinical studies showing that increasing histone acetylation, either via genetic or pharmacological inhibition of HDACs, augments fear extinction and generates a long-term extinction memory that can protect from return of fear phenomena is examined.
...
...

References

SHOWING 1-10 OF 31 REFERENCES
Combining Pharmacotherapy with Cognitive‐Behavioral Interventions for Obsessive‐Compulsive Disorder
TLDR
The state of the art is presented with reference to the consensual recommendations proposed in the last 10 years for obsessive‐compulsive disorder, and the importance of joint efforts of psychological and biological teams to develop new treatments is stressed.
Psychotherapy plus antidepressant for panic disorder with or without agoraphobia
TLDR
Either combined therapy or psychotherapy alone may be chosen as first-line treatment for panic disorder with or without agoraphobia, depending on the patient's preferences.
Recent developments in the research on generalized anxiety disorder
TLDR
New research on drugs, applied relaxation and cognitive therapy suggest that there is room for improving the treatment methods to increase the rate of responders, which is about 50-60% in most studies.
Evidence-based pharmacotherapy of Generalized Anxiety Disorder.
TLDR
Due to their efficacy in GAD and comorbid anxiety and depressive disorders, their tolerability and safety, certain selective serotonin re-uptake inhibitors (escitalopram, paroxetine, sertraline) should be considered the first-line treatment for most patients, although the serotonin-noradrenaline re-ptake inhibitor venlafaxine is a reasonable alternative.
Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
TLDR
The pilot data provide preliminary support for the use of short-term dosing of d-cycloserine as an adjunctive intervention to exposure therapy for SAD.
Sequential treatment of mood and anxiety disorders.
TLDR
The sequential treatment of mood and anxiety disorders does not fall within the realm of maintenance strategies, and is an intensive, 2-stage approach, which is based on the fact that one course of treatment with a specific treatment is unlikely to entail solution to the complex array of symptoms of patients with mood and Anxiety disorders.
Pre-existing antidepressants and the outcome of group cognitive behaviour therapy for social phobia.
TLDR
Pre-existing antidepressants did not significantly enhance or detract from the positive treatment outcome of a structured, group-based CBT program for social phobia.
Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia.
TLDR
All active treatments were superior to PBO on primary outcomes and combined treatment did not yield any further advantage, notwithstanding the benefits of treatment.
...
...